Tersera Therapeutics
QUZYTTIR
Manufacturer:
Tersera Therapeutics
Name:
QUZYTTIR
HCPCS Code Descriptor:
Injection, cetirizine hydrochloride, 0.5 mg
Category:
J Code
HCPCS:
J1201
NDC(s):
70720-0100-25, 70720-0100-10
Primary Type:
Antihistamine
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
QUZYTTIR is an Antihistamine drug manufactured by Tersera Therapeutics and administered via the Intravenous route of administration. The J Code: J1201 is aligned to the drug QUZYTTIR.
Access Pricing and More By Registering
HCPCS Added Date:
7/1/20
HCPCS Effective Date:
7/1/20
HCPCS Short Description:
Inj. cetirizine hcl 0.5mg
Billing and Coding Guide:
https://documents.tersera.com/quzyttir/QuzyttirReimbursementGuideClinic.pdf, https://documents.tersera.com/quzyttir/QuzyttirReimbursementGuideHospital.pdf
Patient Assistance:
https://www.terserasupportsource.com/